Liraglutide Treatment in a Morbidly Obese Adolescent with a <i>MC4R</i> Gene Variant: Side Effects Reduce Success

Çamtosun, Emine; Akinci, Aysehan; Kayas, Leman; Çiftçi, Nurdan; Tekedereli, Ibrahim

Liraglutide Treatment in a Morbidly Obese Adolescent with a MC4R Gene Variant: Side Effects Reduce Success

Çamtosun, Emine; Akinci, Aysehan; Kayas, Leman; Çiftçi, Nurdan; Tekedereli, Ibrahim.

Afiliação

Çamtosun E; Inönü University Faculty of Medicine, Department of Pediatric Endocrinology, Malatya, Turkey
Akinci A; Inönü University Faculty of Medicine, Department of Pediatric Endocrinology, Malatya, Turkey
Kayas L; Inönü University Faculty of Medicine, Department of Pediatric Endocrinology, Malatya, Turkey
Çiftçi N; Inönü University Faculty of Medicine, Department of Pediatric Endocrinology, Malatya, Turkey
Tekedereli I; Inönü University Faculty of Medicine, Department of Medical Biology and Genetics, Malatya, Turkey

J Clin Res Pediatr Endocrinol ; 15(2): 225-229, 2023 05 29.

Article em En | MEDLINE | ID: mdl-34584129

Palavras-chave

obesity; side effect; treatment; Melanocortin-4 receptor defect; liraglutide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article